ECR 2017 / C-2707
Whole-body magnetic resonance (WBMRI) in the staging of monoclonal plasma cell diseases
This poster is published under an
open license. Please read the
disclaimer for further details.
Keywords:
Haematologic, MR, Staging, Haematologic diseases
Authors:
L. Bertuzzo, A. Bissoli, M. C. Ambrosetti, M. Tinelli, R. Pozzi-Mucelli; Verona/IT
DOI:
10.1594/ecr2017/C-2707
References
-
Kyle RA,
Rajkumar SV.
Epidemiology of the plasma-cell disorders.
Best Practice & Research Clin Haematol 2007 Dec; 20(4): 637-64.
-
Palumbo A,
Anderson K.
Multiple myeloma.
N Engl J Med 2011; 364:1046–60.
- International Myeloma Working Group.
Criteria for the classification of monoclonal gammopathies,
multiple myeloma and related disorders: a report of the International Myeloma Working Group.
Br J Haematol 2003 Jun; 121(5):749-57.
- Brenner H,
Gondos A,
Pulte D.
Recent major improvement in long-term survival of younger patients with multiple myeloma.
Blood 2008; 111:2521-6.
-
Terpos E,
Berenson J,
Raje N,
et al.
Management of bone disease in multiple myeloma.
Expert Rev Hematol 2014; 7:113-125.
- Terpos E,
Dimopoulos MA,
Moulopoulos LA.
The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
Am Soc Clin Oncol Educ Book 2016; 35:e407-17.